NCT07079358 Improving Veteran Referral to Cardiac Rehabilitation
| NCT ID | NCT07079358 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Cardiovascular Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 816 participants |
| Start Date | 2026-02-23 |
| Primary Completion | 2028-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 816 participants in total. It began in 2026-02-23 with a primary completion date of 2028-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will test whether the Veterans Cardiac Rehabilitation Referral Program (VCR2P) improves cardiac rehabilitation participation by studying 816 Veterans across three VA medical centers in Nashville, Dallas, and Gainesville over 12 months. The trial compares referral rates from the 6 months before implementing the program to 6 months after, using a "before and after" design since randomization would be impractical. The study will measure whether the program increases the proportion of eligible Veterans who receive cardiac rehabilitation referrals and whether more Veterans actually attend rehabilitation sessions. Additionally, focus groups with physicians, nurses, and Veterans will identify what helps or hinders the program's success, providing essential insights for expanding this intervention to other VA facilities nationwide if it proves effective.
Eligibility Criteria
Inclusion Criteria: * All Veterans hospitalized with acute myocardial infarction, percutaneous coronary intervention, cardiac valve surgery, coronary artery bypass grafting, or systolic heart failure at the three participating VA medical centers (Nashville, Dallas, and Gainesville). Exclusion Criteria: * No exclusion criteria during the intervention period * however, post-hoc analysis will exclude Veterans with documented reasons preventing CR attendance including death during hospitalization or within 30 days of discharge, discharge to inpatient rehabilitation or skilled nursing facilities, significant cognitive impairment, high-risk ventricular arrhythmias, or explicit refusal of CR services.
Contact & Investigator
Justin M Bachmann, MD MPH
PRINCIPAL INVESTIGATOR
Tennessee Valley Healthcare System Nashville Campus, Nashville, TN
Frequently Asked Questions
Who can join the NCT07079358 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07079358 currently recruiting?
Yes, NCT07079358 is actively recruiting participants. Contact the research team at justin.bachmann2@va.gov for enrollment information.
Where is the NCT07079358 trial being conducted?
This trial is being conducted at Gainesville, United States, Nashville, United States, Dallas, United States.
Who is sponsoring the NCT07079358 clinical trial?
NCT07079358 is sponsored by VA Office of Research and Development. The principal investigator is Justin M Bachmann, MD MPH at Tennessee Valley Healthcare System Nashville Campus, Nashville, TN. The trial plans to enroll 816 participants.